322 related articles for article (PubMed ID: 8584936)
1. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
Noben-Trauth N; Kropf P; Müller I
Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
3. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.
Noben-Trauth N; Paul WE; Sacks DL
J Immunol; 1999 May; 162(10):6132-40. PubMed ID: 10229856
[TBL] [Abstract][Full Text] [Related]
4. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.
Yamakami K; Akao S; Tadakuma T; Nitta Y; Miyazaki J; Yoshizawa N
Immunology; 2002 Apr; 105(4):515-23. PubMed ID: 11985672
[TBL] [Abstract][Full Text] [Related]
5. Leishmania susceptibility puzzle gets another twist.
Marx J
Science; 1996 Feb; 271(5251):912-3. PubMed ID: 8584928
[No Abstract] [Full Text] [Related]
6. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
7. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
[TBL] [Abstract][Full Text] [Related]
8. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
Mocci S; Coffman RL
J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development.
Güler ML; Gorham JD; Hsieh CS; Mackey AJ; Steen RG; Dietrich WF; Murphy KM
Science; 1996 Feb; 271(5251):984-7. PubMed ID: 8584935
[TBL] [Abstract][Full Text] [Related]
10. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major.
Nabors GS; Nolan T; Croop W; Li J; Farrell JP
Parasite Immunol; 1995 Nov; 17(11):569-79. PubMed ID: 8817603
[TBL] [Abstract][Full Text] [Related]
11. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.
Titus RG; DeKrey GK; Morris RV; Soares MB
Infect Immun; 2001 Aug; 69(8):5189-92. PubMed ID: 11447205
[TBL] [Abstract][Full Text] [Related]
13. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.
Nabors GS; Farrell JP
Infect Immun; 1994 Dec; 62(12):5498-504. PubMed ID: 7960131
[TBL] [Abstract][Full Text] [Related]
14. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
[TBL] [Abstract][Full Text] [Related]
15. T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
Schwarz T; Remer KA; Nahrendorf W; Masic A; Siewe L; Müller W; Roers A; Moll H
PLoS Pathog; 2013; 9(6):e1003476. PubMed ID: 23825956
[TBL] [Abstract][Full Text] [Related]
16. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
[TBL] [Abstract][Full Text] [Related]
17. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
Padigel UM; Farrell JP
J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
20. IL-13 is a susceptibility factor for Leishmania major infection.
Matthews DJ; Emson CL; McKenzie GJ; Jolin HE; Blackwell JM; McKenzie AN
J Immunol; 2000 Feb; 164(3):1458-62. PubMed ID: 10640762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
